Manuscripts
Showing 1587 manuscripts.
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure
Citation
Steven Sun, Mina Nikanjam, Mark Mirochnick, Kathleen M. Powis, Ahizechukwu C. Eke, Alice Stek, Tim R. Cressy, Kristina M. Brooks, Brookie M. Best, Edmund V. Capparelli, Jeremiah D. Momper. Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure. Journal of Clinical Pharmacology. 2026. 66: e70134. PMID: 41405169Year
2026
Journal
Journal of Clinical Pharmacology
Study
IMPAACT 2026
Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir-rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study
Citation
Aditya H. Gaur, Kristin Baltrusaitis, Edmund V. Capparelli, John H. Moye, Dwight E. Yin, Gaerolwe Masheto, Sarah Buisson, Conn M. Harrington, Mark A. Marzinke, Elizabeth D. Lowenthal, Rachel Scheckter, Andi Ace, Shawn Ward, Ryan Milligan, Kyle Whitson, Jenny Huang, S. Y. Amy Cheung, Brookie M. Best, Ellen Townley, Gilly Roberts, Thomas Kakuda, Eileen Birmingham, Sisinyana Ruth Mathiba, Linda Aurpibul, Violet Korutaro, Christiana Smith, Faeezah Patel, Evette Moodley, Carolyn Bolton Moore, IMPAACT 2017 Collaborators, IMPAACT 2017 Team. Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir-rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study. Lancet HIV. 2026. PMID: 41547359Year
2026
Journal
Lancet HIV
Study
IMPAACT 2017
Acceptability and tolerability of long-acting injectable cabotegravir-rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial
Citation
Elizabeth D. Lowenthal, Jennifer Chapman, Kristin Baltrusaitis, Grace Kovic, Sanjna Merchant, Kaleb Branch, Chermiqua Tsosie, Martina Zapata Vaca, Barbara Heckman, Rodica Van Solingen-Ristea, Conn M. Harrington, Dwight E. Yin, Ellen Townley, Michael Whitton, Allison L. Agwu, Christiana Smith, Mary E. Paul, Avy Violari, Evette Moodley, Maxensia Owor, Kulkanya Chokephaibulkit, Samantha Fry, Jennifer Jao, Charles D. Mitchell, Sarah Buisson, Andi Ace, Irina Kolobova, Carolyn Bolton Moore, Aditya H. Gaur, IMPAACT 2017 Collaborators, IMPAACT 2017 Team. Acceptability and tolerability of long-acting injectable cabotegravir-rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial. Lancet HIV. 2026. 13: e95-e103. PMID: 41547358Year
2026
Journal
Lancet HIV
Study
IMPAACT 2017
Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infants
Citation
Dustin Huynh, Mina Nikanjam, Coleen K. Cunningham, Elizabeth J. McFarland, Petronella Muresan, Charlotte Perlowski, Dwight E. Yin, Jack Moye, Hans Speigel, Lucio Gama, Martin Gaudinski, Edmund V. Capparelli. Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infants. Journal of Antimicrobial Chemotherapy. 2026. 81: dkaf449. PMID: 41549660Year
2026
Journal
Journal of Antimicrobial Chemotherapy
Study
P1112
Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among women with and without ARV exposure
Citation
Maxensia Owor, Kristin Baltrusaitis, Patricia DeMarrais, Lisa M. Frenkel, Brookie M. Best, Lynda Stranix-Chibanda, Dhayendre Moodley, Avy Violari, Brenda Kakayi, Sheila Styrchak, Ingrid A. Beck, Jeremiah D. Momper, Patricia M. Flynn, Mary Glenn Fowler. Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among women with and without ARV exposure. Journal of Acquired Immune Deficiency Syndromes. 2026. PMID: 41837779Year
2026
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077BF
Tuberculosis preventive therapy in postpartum women with HIV modifies M. tuberculosis-specific and nonspecific immune responses
Citation
Damayanti D. Yengkhom, Grace Montepiedra, Gaerolwe Masheto, Deo Wabire, Lynda Stranix-Chibanda, Allen Matubu, Avy Violari, Gerhard Theron, Amita Gupta, Adriana Weinberg. Tuberculosis preventive therapy in postpartum women with HIV modifies M. tuberculosis-specific and nonspecific immune responses. Frontiers in Immunology. 2026. 17: 1722621. PMID: 41890718Year
2026
Journal
Frontiers in Immunology
Study
P1078
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV
Citation
Risa Hoffman, Sean Brummel, Mauricio Pinilla, Grace Malonga, Lameck Chinula, Lynda Stranix-Chibanda, Elizabeth S. Machado, Shilpa Naik, Mobeen H. Rathore, Jose Pilotto, Gaerolwe Masheto, Jeffrey S. A. Stringer, Roger Shapiro, Charles D. Mitchell, Katie McCarthy, Tim Cressey, Sherika Hanley, Patrick Jean-Philippe, Chelsea Stotz, Paul Sax, Judith S. Currier, Shahin Lockman, IMPAACT 2010/VESTED Study Team. Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV. Clinical Infectious Diseases. 2026. PMID: 41973953Year
2026
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010
Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV
Citation
Emily A. Barr, Kristin Baltrusaitis, Betsy D. Kennard, Graham J. Emslie, Chelsea Krotje, Kevin Knowles, Sarah Buisson, Lauren Bergam, Jaime Deville, Susan Gillespie, Melissa Shikora, Ellen Townley, David E. Shapiro, Larry K. Brown. Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV. Journal of Child & Adolescent Mental Health. 2025. 36: 108-123. PMID: 39550758Year
2025
Journal
Journal of Child & Adolescent Mental Health
Study
IMPAACT 2002
Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy
Citation
Ahizechukwu Eke, Sean Brummel, Muktar H Aliyu, Lynda Stranix-Chibanda, George Uchenna Eleje, Ifeanyi Ezebialu, Violet Korutaro, Deo Wabwire, Allen Matubu, Tapiwa Mbengeranwa, Nahida Chakhtoura, Lameck Chinula, Katie McCarthy, Kevin Knowles, Chelsea Krotje, MacRae F Linton, Kelly Dooley, Paul Sax, Todd Brown, Shahin Lockman, IMPAACT 2010/VESTED Study Team. Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy. Clinical Infectious Diseases. 2025. 80: 594-601. PMID: 39219495Year
2025
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010